Clinical profile and infection burden among children with nephrotic syndrome
DOI:
https://doi.org/10.18203/2349-3291.ijcp20261136Keywords:
Nephrotic syndrome, Children, Clinical profile, Infection burden, Urinary tract infectionAbstract
Background: Nephrotic syndrome is a common chronic kidney disorder in children and is frequently complicated by infections, which contribute significantly to morbidity and hospitalization. Understanding the clinical profile and infection burden is essential for improving management and outcomes.
Methods: This cross-sectional study was conducted in the Department of Pediatric Nephrology at Dhaka Shishu (Children) Hospital from January 2010 to November 2010. This study included 115 children aged 1-13 years diagnosed with nephrotic syndrome. Detailed clinical evaluation and relevant laboratory investigations were performed. Sociodemographic characteristics, presenting features and infectious complications were recorded and analyzed using appropriate statistical methods.
Results: The majority of children were between 2-6 years of age, with a mean age of 5.29±2.7 years. Male predominance was observed, with 70.43% (81) males and 29.57% (34) females (male-female ratio 2.3:1). Most patients were from rural areas (73.91%) and 52.17% belonged to poor socioeconomic backgrounds. Almost all patients presented with generalized edema, proteinuria and oliguria. Fever was present in 26.10% of cases and abdominal pain in 1.70%. Infection was a major complication. Urinary tract infection (UTI) was the most common infection, affecting 44.35% of patients, followed by pneumonia (6.09%), septicemia (4.35%), cellulitis (3.48%) and peritonitis (1.74%).
Conclusions: Nephrotic syndrome predominantly affects young male children and is associated with a considerable infection burden, particularly UTI. Early recognition and prompt management of infections are crucial to reduce morbidity and improve clinical outcomes.
References
Alwadhi RK, Mathew JL, Rath B. Clinical profile of children with nephrotic syndrome not on glucorticoid therapy, but presenting with infection. J Paediat Child Health. 2004;40(1‐2):28-32.
Guha P, De A, Ghosal M. Behavior profile of children with nephrotic syndrome. Indian J Psychiat. 2009;51(2):122-6.
Eddy AA, Symons JM. Nephrotic syndrome in childhood. The lancet. 2003;362(9384):629-39.
Mishra OP, Basu B, Upadhyay SK, Prasad R, Schaefer F. Behavioural abnormalities in children with nephrotic syndrome. Nephrol Dialysis Transplantation. 2010;25(8):2537-41.
Cox TM. Gaucher disease: clinical profile and therapeutic developments. Biologics: Targets and Therapy. 2010:299-313.
Bay AG, Anacleto F. Clinical and laboratory profile of urinary tract infection among children at the outpatient clinic of a tertiary hospital. PIDSP J. 2010;11(1):10-6.
Uncu N, Bülbül M, Yıldız N, Noyan A, Koşan C, Kavukçu S, et al. Primary peritonitis in children with nephrotic syndrome: results of a 5-year multicenter study. Europ J Pediat. 2010;169(1):73-6.
Hassan M. Aetiology, laboratory and clinical profile of chronic renal failure [Doctoral dissertation, Rajiv Gandhi University of Health Sciences (India)]. 2006
Bawa MI. A Study of the Clinical Profile of Typhoid Fever in Pediatric Age Group in an Under-Served Area Of Urban Bangalore [Doctoral dissertation, Rajiv Gandhi University of Health Sciences (India)]. 2010
Hull RP, Goldsmith DJ. Nephrotic syndrome in adults. Bmj. 2008;336(7654):1185-9.
Schachter AD. The pediatric nephrotic syndrome spectrum: clinical homogeneity and molecular heterogeneity. Pediat Transplantat. 2004;8(4):344-8.
Lande MB, Gullion C, Hogg RJ, Gauthier B, Shah B, Leonard MB, et al. Long versus standard initial steroid therapy for children with the nephrotic syndrome: A report from the Southwest Pediatric Nephrology Study Group. Pediat Nephrol. 2003;18(4):342-6.
Doe JY, Funk M, Mengel M, Doehring E, Ehrich JH. Nephrotic syndrome in African children: lack of evidence for ‘tropical nephrotic syndrome’? Nephrol Dialysis Transplantat. 2006;21(3):672-6.
Warady BA, Chadha V. Chronic kidney disease in children: the global perspective. Pediatric nephrology. 2007;22(12):1999-2009.
Breman JG. Ears of the hippopotamus: manifestations, determinants and estimates of the malaria burden. Am J Trop Med Hyg. 2001;64(1-2):1-11.
Brogan PA, Trompeter RS, Abeyagunawardena A, Dillon MJ. Immunosuppressive therapy of childhood idiopathic nephrotic syndrome. Expert Opin Pharmacoth. 2002;3(5):513-9.
Bagga A. Management of steroid resistant nephrotic syndrome. Indian Pediat. 2009;46(1):10.
Madhi SA, Petersen K, Madhi A, Wasas A, Klugman KP. Impact of human immunodeficiency virus type 1 on the disease spectrum of Streptococcus pneumoniae in South African children. Pediat Infect Dis J. 2000;19(12):1141-7.
Prasad N, Gulati S, Sharma RK, Singh U, Ahmed M. Pulse cyclophosphamide therapy in steroid-dependent nephrotic syndrome. Pediat Nephrol. 2004;19(5):494-8.
Iyengar A, Karthik S, Kumar A, Biswas S, Phadke K. Cyclosporine in steroid dependent and resistant childhood nephrotic syndrome. Indian Pediat. 2006;43(1):14.
Abeyagunawardena AS, Goldblatt D andrews N, Trompeter RS. Risk of relapse after meningococcal C conjugate vaccine in nephrotic syndrome. The Lancet. 2003;362(9382):449-50.